Sol-Gel Technologies (NASDAQ:SLGL - Get Free Report)'s stock had its "hold (c-)" rating restated by Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.
Separately, Wall Street Zen upgraded Sol-Gel Technologies to a "buy" rating in a report on Saturday, September 13th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of "Hold".
Check Out Our Latest Stock Report on Sol-Gel Technologies
Sol-Gel Technologies Stock Performance
SLGL opened at $39.32 on Wednesday. Sol-Gel Technologies has a 52-week low of $4.01 and a 52-week high of $52.26. The firm has a market capitalization of $109.70 million, a PE ratio of -31.97 and a beta of 1.29. The business's 50-day simple moving average is $23.69 and its 200 day simple moving average is $12.84.
Sol-Gel Technologies (NASDAQ:SLGL - Get Free Report) last released its earnings results on Friday, August 15th. The company reported $4.17 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.67) by $4.84. Sol-Gel Technologies had a negative return on equity of 11.80% and a negative net margin of 14.25%.The business had revenue of $17.26 million for the quarter, compared to analyst estimates of $2.86 million. On average, research analysts forecast that Sol-Gel Technologies will post -0.28 earnings per share for the current year.
About Sol-Gel Technologies
(
Get Free Report)
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sol-Gel Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sol-Gel Technologies wasn't on the list.
While Sol-Gel Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
